compound glp 1 tirzepatide Injection for Seniors With Medicare Compounded GLP-1 & GIP

This hormone helps to regulate blood sugar levels by increasing insulin production when blood sugar is high and by reducing the amount of glucose (sugar) produced by the liver

Tirzepatide is technically the combination of two different drugs: a glucagon-like peptide-1 (GLP-1) receptor agonist and a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. Because of this, Tirzepatide is also known as a dual GLP-1/GIP receptor agonist. These are both hormones that your system releases after you eat

Dopamine-producing neurons are lost in Parkinson's disease, a neurodegenerative condition

Patients on any oral antihyperglycemic agent in monotherapy (N=212) or on a PPAR agent in combination therapy (N=106) or not on an antihyperglycemic agent (off therapy for at least 8 weeks, N=34) were switched to monotherapy with pioglitazone (at a dose of 30-45 mg per day), and completed a run-in period of approximately 12 weeks in duration